PURPOSE: Idiopathic generalized epilepsies (IGE) comprise a group of clinical syndromes associated with spike wave discharges, putatively linked to alterations in neurotransmission. The purpose of this study was to investigate whether patients with IGE have altered glutamine and γ-aminobutyric acid (GABA) levels indicative of altered excitatory and inhibitory neurotransmission in frontal regions. MATERIALS AND METHODS: Single-voxel MEGA-edited PRESS magnetic resonance imaging (MRI) spectra were acquired from a 30-mL voxel in the dorsolateral prefrontal cortex in 13 patients with IGE (8 female) and 16 controls (9 female) at 3T. Metabolite concentrations were derived using LCModel. Differences between groups were investigated using an unpaired t-test. RESULTS: Patients with IGE were found to have significantly higher glutamine than controls (P = 0.02). GABA levels were also elevated in patients with IGE (P = 0.03). CONCLUSION: Patients with IGE have increased frontal glutamine and GABA compared with controls. Since glutamine has been suggested to act as a surrogate for metabolically active glutamate, it may represent a marker for excitatory neurotransmission.
PURPOSE:Idiopathic generalized epilepsies (IGE) comprise a group of clinical syndromes associated with spike wave discharges, putatively linked to alterations in neurotransmission. The purpose of this study was to investigate whether patients with IGE have altered glutamine and γ-aminobutyric acid (GABA) levels indicative of altered excitatory and inhibitory neurotransmission in frontal regions. MATERIALS AND METHODS: Single-voxel MEGA-edited PRESS magnetic resonance imaging (MRI) spectra were acquired from a 30-mL voxel in the dorsolateral prefrontal cortex in 13 patients with IGE (8 female) and 16 controls (9 female) at 3T. Metabolite concentrations were derived using LCModel. Differences between groups were investigated using an unpaired t-test. RESULTS:Patients with IGE were found to have significantly higher glutamine than controls (P = 0.02). GABA levels were also elevated in patients with IGE (P = 0.03). CONCLUSION:Patients with IGE have increased frontal glutamine and GABA compared with controls. Since glutamine has been suggested to act as a surrogate for metabolically active glutamate, it may represent a marker for excitatory neurotransmission.
Authors: Edward J Novotny; Robert K Fulbright; Phillip L Pearl; K Michael Gibson; Douglas L Rothman Journal: Ann Neurol Date: 2003 Impact factor: 10.422
Authors: Paul G Mullins; David J McGonigle; Ruth L O'Gorman; Nicolaas A J Puts; Rishma Vidyasagar; C John Evans; Richard A E Edden Journal: Neuroimage Date: 2012-12-13 Impact factor: 6.556
Authors: Clara Quetscher; Ali Yildiz; Shalmali Dharmadhikari; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Ulrike Dydak; Christian Beste Journal: Brain Struct Funct Date: 2014-08-26 Impact factor: 3.270
Authors: Zaiyang Long; Jonathan P Dyke; Ruoyun Ma; Chaorui C Huang; Elan D Louis; Ulrike Dydak Journal: NMR Biomed Date: 2015-08-28 Impact factor: 4.044
Authors: Swaantje Casjens; Urike Dydak; Shalmali Dharmadhikari; Anne Lotz; Martin Lehnert; Clara Quetscher; Christoph Stewig; Benjamin Glaubitz; Tobias Schmidt-Wilcke; David Edmondson; Chien-Lin Yeh; Tobias Weiss; Christoph van Thriel; Lennard Herrmann; Siegfried Muhlack; Dirk Woitalla; Michael Aschner; Thomas Brüning; Beate Pesch Journal: Neurotoxicology Date: 2017-08-11 Impact factor: 4.294
Authors: Murat İlhan Atagün; Elif Muazzez Şıkoğlu; Çağlar Soykan; Can Serdar Süleyman; Semra Ulusoy-Kaymak; Ali Çayköylü; Oktay Algın; Mary Louise Phillips; Dost Öngür; Constance Mary Moore Journal: Neurosci Lett Date: 2016-11-24 Impact factor: 3.046
Authors: Lisa A Bartolomeo; Andrew M Wright; Ruoyun E Ma; Tom A Hummer; Michael M Francis; Andrew C Visco; Nicole F Mehdiyoun; Amanda R Bolbecker; William P Hetrick; Ulrike Dydak; John Barnard; Brian F O'Donnell; Alan Breier Journal: Int J Psychophysiol Date: 2019-05-23 Impact factor: 2.997
Authors: Ivan I Kirov; Ruben Kuzniecky; Hoby P Hetherington; Brian J Soher; Matthew S Davitz; James S Babb; Heath R Pardoe; Jullie W Pan; Oded Gonen Journal: Epilepsy Res Date: 2017-12-02 Impact factor: 3.045